G-CSF enhances the proliferation and mobilization, but not the maturation rate, of murine myeloid cells

European Journal of Haematology

Volumn 87, Issue 4, 2011, Pages 302-311

  Knudsen, Eirunn ^a   Iversen, Per Ole ^a,b   Bøyum, Arne ^a   Seierstad, Therese ^c,d   Nicolaysen, Gunnar ^a   Benestad, Haakon B ^a  

^a UNIVERSITY OF OSLO   (Norway)

^b ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^c OSLO UNIVERSITY HOSPITAL   (Norway)

^d UNIVERSITY OF SOUTH EASTERN NORWAY   (Norway)

Author keywords

Bone marrow; BrdU; Granulopoiesis; Mice; Pegfilgrastim

Indexed keywords

LEUKOCYTE ANTIGEN; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD; BONE MARROW; BONE MARROW CELL; CELL COMPARTMENTALIZATION; CELL CYCLE S PHASE; CELL DENSITY; CELL MATURATION; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; FLOW MEASUREMENT; GRANULOCYTE; GRANULOPOIESIS; IN SITU HYBRIDIZATION; MOUSE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; STEM CELL MOBILIZATION;

ANIMALS; BONE MARROW CELLS; CELL PROLIFERATION; FEMALE; GRANULOCYTE COLONY-STIMULATING FACTOR; MICE; MICE, INBRED BALB C;

EID: 80053266731     PISSN: 09024441     EISSN: 16000609     Source Type: Journal    
DOI: 10.1111/j.1600-0609.2011.01658.x     Document Type: Article

References (43)

1. O'Neill LAJ. Immunity's early-warning system. Sci Am 2005;292:38-45.
2. Theilgaard-Mönch K, Jacobsen LC, Borup R, Rasmussen T, Bjerregaard MD, Nielsen FC, Cowland JB, Borregaard N. The transcriptional program of terminal granulocytic differentiation. Blood 2005;105:1785-96.
3. Metcalf D. Control of granulocytes and macrophages - molecular, cellular, and clinical aspects. Science 1991;254:529-33.
4. Carlsson G, Melin M, Dahl N, Ramme KG, Nordenskjöld M, Palmblad J, Henter JI, Fadeel B. Kostmann syndrome or infantile genetic agranulocytosis, part two: understanding the underlying genetic defects in severe congenital neutropenia. Acta Paediatr 2007;96:813-9.
5. Horwitz M, Benson KF, Person RE, Aprikyan AG, Dale DC. Mutations in ELA2, encoding neutrophil elastase, define a 21-day biological clock in cyclic haematopoiesis. Nat Genet 1999;23:433-6.
6. Price TH, Chatta GS, Dale DC. Effect of recombinant granulocyte colony-stimulating factor on neutrophil kinetics in normal young and elderly humans. Blood 1996;88:335-40.
7. Colotta F, Re F, Polentarutti N, Sozzani S, Mantovani A. Modulation of granulocyte survival and programmed cell-death by cytokines and bacterial products. Blood 1992;80:2012-20.
8. Williams GT, Smith CA, Spooncer E, Dexter TM, Taylor DR. Hematopoietic colony stimulating factors promote cell-survival by suppressing apoptosis. Nature 1990;343:76-9.
9. Metcalf D, Nicola NA. The clonal proliferation of normal mouse hematopoietic cells: enhancement and suppression by colony-stimulating factor combinations. Blood 1992;79:2861-6.
10. Begley CG, Nicola NA, Metcalf D. Proliferation of normal human promyelocytes and myelocytes after a single pulse stimulation by purified GM-CSF or G-CSF. Blood 1988;71:640-5.
11. Cohen AM, Zsebo KM, Inoue H, Hines D, Boone TC, Chazin VR, Tsai L, Ritch T, Souza LM. In vivo stimulation of granulopoiesis by recombinant human granulocyte colony-stimulating factor. Proc Natl Acad Sci USA 1987;84:2484-8.
12. Gregory AD, Hogue LA, Ferkol TW, Link DC. Regulation of systemic and local neutrophil responses by G-CSF during pulmonary Pseudomonas aeruginosa infection. Blood 2007;109:3235-43.
13. Kawakami M, Tsutsumi H, Kumakawa T, Abe H, Hirai M, Kurosawa S, Mori M, Fukushima M. Levels of serum granulocyte colony-stimulating factor in patients with infections. Blood 1990;76:1962-4.
14. Lord BI, Molineux G, Pojda Z, Souza LM, Mermod JJ, Dexter TM. Myeloid cell kinetics in mice treated with recombinant interleukin-3, granulocyte colony-stimulating factor (CSF), or granulocyte-macrophage CSF in vivo. Blood 1991;77:2154-9.
15. Lord BI, Bronchud MH, Owens S, Chang J, Howell A, Souza L, Dexter TM. The kinetics of human granulopoiesis following treatment with granulocyte colony-stimulating factor in vivo. Proc Natl Acad Sci USA 1989;86:9499-503.
16. Nicola NA, Metcalf D, Matsumoto M, Johnson GR. Purification of a factor inducing differentiation in murine myelomonocytic leukemia cells - identification as granulocyte colony-stimulating factor. J Biol Chem 1983;258:9017-23.
17. Lord BI. Myeloid cell kinetics in response to hematopoietic growth factors. Baillière's Clin Haematol 1992;5:533-50.
18. Wengner AM, Pitchford SC, Furze RC, Rankin SM. The coordinated action of G-CSF and ELR plus CXC chemokines in neutrophil mobilization during acute inflammation. Blood 2008;111:42-9.
19. Kim HK, De La Luz Sierra M, Williams CK, Gulino AV, Tosato G. G-CSF down-regulation of CXCR4 expression identified as a mechanism for mobilization of myeloid cells. Blood 2006;108:812-20.
20. Wang XL, Fjerdingstad H, Strøm-Gundersen I, Benestad HB. Maturation rate of mouse neutrophilic granulocytes: acceleration by retardation of proliferation, but no detectable influence from G-CSF or stromal cells. Stem Cells 1999;17:253-64.
21. Benestad HB, Rytömaa T. Regulation of maturation rate of mouse granulocytes. Cell Tissue Kinet 1977;10:461-8.
22. Anderlini P, Przepiorka D, Champlin R, Körbling M. Biologic and clinical effects of granulocyte colony-stimulating factor in normal individuals. Blood 1996;88:2819-25.
23. Molineux G. The design and development of pegfilgrastim (PEG-rmetHuG-CSF, neulasta®). Curr Pharm Des 2004;10:1235-44.
24. Zamboni WC. Pharmacokinetics of pegfilgrastim. Pharmacotherapy 2003;23:9S-14S.
25. Johnston E, Crawford J, Blackwell S, et al. Randomized, dose-escalation study of SD/01 compared with daily filgrastim in patients receiving chemotherapy. J Clin Oncol 2000;18:2522-8.
26. Molineux G, Kinstler O, Briddell B, et al. A new form of Filgrastim with sustained duration in vivo and enhanced ability to mobilize PBPC in both mice and humans. Exp Hematol 1999;27:1724-34.
27. Crawford J. Safety and efficacy of pegfilgrastim in patients receiving myelosuppressive chemotherapy. Pharmacotherapy 2003;23:15S-9S.
28. Schittek B, Rajewsky K, Förster I. Dividing cells in bone-marrow and spleen incorporate bromodeoxyuridine with high efficiency. Eur J Immunol 1991;21:235-8.
29. Rocha B, Penit C, Baron C, Vasseur F, Dautigny N, Freitas AA. Accumulation of bromodeoxyuridine-labeled cells in central and peripheral lymphoid organs - minimal estimates of production and turnover rates of mature lymphocytes. Eur J Immunol 1990;20:1697-708.
30. Donohue DM, Gabrio BW, Finch CA. Quantitative measurement of hematopoietic cells of the marrow. J Clin Invest 1958;37:1564-70.
31. Terashima T, English D, Hogg JC, Van Eeden SF. Release of polymorphonuclear leukocytes from the bone marrow by interleukin-8. Blood 1998;92:1062-9.
32. Basu S, Hodgson G, Katz M, Dunn AR. Evaluation of role of G-CSF in the production, survival, and release of neutrophils from bone marrow into circulation. Blood 2002;100:854-61.
33. Lagasse E, Weissman IL. Flow cytometric identification of murine neutrophils and monocytes. J Immunol Methods 1996;197:139-50.
34. Hestdal K, Ruscetti FW, Ihle JN, Jacobsen SE, Dubois CM, Kopp WC, Longo DL, Keller JR. Characterization and regulation of RB6-8C5 antigen expression on murine bone marrow cells. J Immunol 1991;147:22-8.
35. Fleming TJ, Fleming ML, Malek TR. Selective expression of Ly-6G on myeloid lineage cells in mouse bone-marrow - RB6-8C5 mAb to granulocyte-differentiation antigen (Gr-1) detects members of the Ly-6 Family. J Immunol 1993;151:2399-408.
36. Nagendra S, Schlueter AJ. Absence of cross-reactivity between murine Ly-6C and Ly-6G. Cytometry A 2004;58:195-200.
37. Geissmann F, Jung S, Littman DR. Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity 2003;19:71-82.
38. high polymorphonuclear leukocytes and NK cells act via IL-15 to clear intracellular Haemophilus influenzae in experimental murine peritonitis and pneumonia. J Immunol 2007;179:5407-14.
39. Knudsen E, Iversen PO, van Rooijen N, Benestad HB. Macrophage-dependent regulation of neutrophil mobilization and chemotaxis during development of sterile peritonitis in the rat. Eur J Haematol 2002;69:284-96.
40. Østby I, Benestad HB, Grøttum P. Mathematical modeling of human granulopoiesis: the possible importance of regulated apoptosis. Math Biosci 2003;186:1-27.
41. Molineux G, Pojda Z, Dexter TM. A comparison of hematopoiesis in normal and splenectomized mice treated with granulocyte colony-stimulating factor. Blood 1990;75:563-9.
42. Uchida T, Yamagiwa A. Kinetics of rG-CSF-induced neutrophilia in mice. Exp Hematol 1992;20:152-5.
43. Benestad HB, Laerum OD. The neutrophilic granulocyte. Curr Top Pathol 1989;79:7-36.